Form 8-K - Current report:
SEC Accession No. 0001193125-24-071353
Filing Date
2024-03-19
Accepted
2024-03-19 16:31:05
Documents
13
Period of Report
2024-03-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d780027d8k.htm   iXBRL 8-K 34977
  Complete submission text file 0001193125-24-071353.txt   163840

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grph-20240319.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20240319_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20240319_pre.xml EX-101.PRE 11708
16 EXTRACTED XBRL INSTANCE DOCUMENT d780027d8k_htm.xml XML 3748
Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 24763890
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)